FairJourney Biologics News and Activities

View the org chart displaying its 14 main executives

Most searched biographies at FairJourney Biologics

• Werner Lanthaler, Chief Executive Officer and Chairman of the Board
• Rita Teles, Chief Financial Officer
• Alberto Pinto, Global Head of Marketing

Popular executive movements at FairJourney Biologics

• António Parada, Chief Executive Officer, has left the company  (posted on October 8 2025).
• Werner Lanthaler has joined the company as Chief Executive Officer  (posted on October 8 2025).

Create your alert
to follow the executive moves at FairJourney Biologics.

FairJourney Biologics has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by FairJourney Biologics

• News & Events - FairJourney
• News & Events - FairJourney
• News & Events - FairJourney
• The Antibody Series 2022 – FairJourney

Social media about FairJourney Biologics

• FairJourney Biologics on Wikipedia, Google News & Yahoo Finance
• FairJourney Biologics on LinkedIn, X (Twitter) & YouTube